Company: ABBV
Filing Date: 2025-08-04
Form Type: 10-Q
Source: 0001551152-25-000040
Chunk: 55

Company: AbbVie Inc.
Filing Date: 2025-08-04
Form: 10-Q
Item: Part I, Item 1
Chunk 55
---
 $113 $193 $228 Other NeuroscienceUnited States$51 $57 $106 $118 International4 5 8 9 Total$55 $62 $114 $127 

2025 Form 10-Q | 25

Three months endedJune 30,Six months endedJune 30,(in millions)2025202420252024OncologyImbruvicaUnited States$543 $595 $1,072 $1,205 Collaboration revenues211 238 420 466 Total$754 $833 $1,492 $1,671 VenclextaUnited States$321 $300 $633 $581 International370 337 723 670 Total$691 $637 $1,356 $1,251 ElahereUnited States$138 $128 $303 $192 International21 — 35 — Total$159 $128 $338 $192 EpkinlyCollaboration revenues$49 $29 $85 $51 International21 7 36 12 Total$70 $36 $121 $63 Other OncologyUnited States$2 $— $2 $— AestheticsBotox CosmeticUnited States$410 $450 $705 $839 International282 279 543 523 Total$692 $729 $1,248 $1,362 Juvederm CollectionUnited States$105 $138 $180 $244 International155 205 311 396 Total$260 $343 $491 $640 Other AestheticsUnited States$282 $275 $552 $556 International45 43 90 81 Total$327 $318 $642 $637 Eye CareOzurdexUnited States$30 $35 $60 $69 International95 89 188 186 Total$125 $124 $248 $255 Lumigan/GanfortUnited States$52 $42 $100 $71 International51 61 109 123 Total$103 $103 $209 $194 Alphagan/CombiganUnited States$— $13 $26 $28 International